×

Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione

DC
  • US 9,993,467 B2
  • Filed: 12/23/2015
  • Issued: 06/12/2018
  • Est. Priority Date: 05/19/2009
  • Status: Active Grant
First Claim
Patent Images

1. An oral dosage form in the form of a capsule which comprises:

  • 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;

         2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is a mixture of starch and mannitol; and

    wherein the ratio of mannitol;

    starch in the dosage form is from about 1;

    1 to about 1;

    1.5.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×